Q2 2026 Holdings
Filed 2026-08-14 | 82 holdings | $143.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Contineum Therapeutics(CTNM) | CL A | 21217B100 | $11.9M | 727,587 | 8.3% |
| Shoulder Innovations(SI) | COMMON STOCK | 82537J108 | $8.7M | 430,407 | 6.1% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $7.6M | 6,354 | 5.3% |
| Unitedhealth GRP Inc(UNH) | COM | 91324P102 | $5.5M | 13,235 | 3.8% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $4.6M | 18,218 | 3.2% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $4.0M | 41,987 | 2.8% |
| Biontech SE(BNTX) | SP ADR | 09075V102 | $3.9M | 41,869 | 2.7% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $3.7M | 78,310 | 2.6% |
| Dexcom Inc(DXCM) | COM | 252131107 | $3.4M | 50,756 | 2.4% |
| Arcus Biosciences(RCUS) | COM | 03969F109 | $3.4M | 110,870 | 2.4% |
| Amgen Inc(AMGN) | COM | 031162100 | $3.3M | 9,210 | 2.3% |
| Summit Therapeutics(SMMT) | COM | 86627T108 | $3.2M | 220,180 | 2.2% |
| Irhythm Holdings Inc(IRTC) | COM | 450056106 | $3.1M | 26,070 | 2.2% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $3.1M | 12,200 | 2.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $2.8M | 21,480 | 1.9% |
| Arrivent Biopharma(AVBP) | COM | 04272N102 | $2.7M | 79,043 | 1.9% |
| Vertex Pharma(VRTX) | COM | 92532F100 | $2.7M | 5,432 | 1.9% |
| Argenx SE(ARGX) | SP ADR | 04016X101 | $2.6M | 2,831 | 1.8% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $2.6M | 20,620 | 1.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $2.5M | 23,216 | 1.7% |
| Tectonic Therapeutic(TECX) | COM | 878972108 | $2.4M | 71,009 | 1.7% |
| Intuitive Surgic Inc(ISRG) | COM NEW | 46120E602 | $2.3M | 5,850 | 1.6% |
| Immatics NV(IMTX) | SHS | N44445109 | $2.3M | 224,928 | 1.6% |
| Stryker Corp(SYK) | COM | 863667101 | $2.2M | 7,129 | 1.6% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $2.2M | 119,923 | 1.5% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $2.2M | 121,300 | 1.5% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $2.2M | 61,100 | 1.5% |
| Iqvia Holdings Inc(IQV) | COM | 46266C105 | $2.1M | 10,848 | 1.5% |
| Pulse Biosciences Inc(PLSE) | COM | 74587B101 | $1.9M | 67,895 | 1.3% |
| Danaher Corp(DHR) | COM | 235851102 | $1.8M | 9,597 | 1.3% |
| Thermo Fisher Scientific(TMO) | COM | 883556102 | $1.8M | 3,508 | 1.2% |
| Abbott Labs(ABT) | COM | 002824100 | $1.6M | 18,080 | 1.1% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $1.6M | 185,900 | 1.1% |
| Boston Scientific(BSX) | COM | 101137107 | $1.6M | 36,330 | 1.1% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $1.5M | 21,950 | 1.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $1.4M | 16,330 | 1.0% |
| Regeneron Pharmctcls(REGN) | COM | 75886F107 | $1.4M | 2,169 | 0.9% |
| CVS Health Corp(CVS) | COM | 126650100 | $1.3M | 13,000 | 0.9% |
| Edwards Lifesciences(EW) | COM | 28176E108 | $1.3M | 14,826 | 0.9% |
| Trevi Therapeutics(TRVI) | COM | 89532M101 | $1.2M | 65,596 | 0.9% |
| Bristol Myers Squibb(BMY) | COM | 110122108 | $1.2M | 21,150 | 0.9% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $1.1M | 25,573 | 0.8% |
| Cogent Biosciences(COGT) | COM | 19240Q201 | $1.0M | 26,740 | 0.7% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $876.3K | 11,100 | 0.6% |
| Tarsus Pharmaceuticals(TARS) | COM | 87650L103 | $836.2K | 13,285 | 0.6% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $784.1K | 71,480 | 0.5% |
| Centene Corp del(CNC) | COM | 15135B101 | $770.3K | 12,000 | 0.5% |
| United Therapeutics(UTHR) | COM | 91307C102 | $742.3K | 1,370 | 0.5% |
| Hinge Health Inc(HNGE) | CL A | 433313103 | $725.8K | 8,744 | 0.5% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $705.8K | 10,111 | 0.5% |